Mei Lin Go

Introduction

Mei Lin Go is an accomplished inventor based in Singapore. With a total of three patents to her name, she has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for medical use.

Latest Patents

Mei Lin Go's latest inventions include novel compounds designed to inhibit particular biochemical pathways. One such patent details the development of ICMT inhibitors, presenting a 1,3,5-substituted indole structure with specific chemical modifications. This invention features a substituent at position 1 as a C6 to C12 alkyl group and at position 3 as CHNRR, where R can vary from hydrogen to substituted alkyls. Additionally, her work encompasses benzylidene-indolinone compounds characterized as tyrosine kinase inhibitors, which have potential applications in treating diseases, including various forms of cancer.

Career Highlights

Mei Lin Go is currently affiliated with the National University of Singapore, where she engages in cutting-edge research. Her work not only showcases her inventive prowess but also contributes to the growing body of research focused on therapeutic agents in the medical field.

Collaborations

Throughout her career, Mei Lin Go has collaborated with other prominent researchers, including Mei-Wang Casey and Patrick J. Casey. These partnerships reflect a commitment to advancing knowledge and the development of innovative solutions in medicinal chemistry.

Conclusion

Mei Lin Go exemplifies the spirit of innovation and dedicated research in her endeavors. With her latest patents, she continues to impact the field of medicine positively, paving the way for potential treatments for serious health conditions. Her work, carried out at the National University of Singapore, underscores the collaborative efforts within the scientific community to bring new inventions to life.